Ketogenic Diet for Refractory Status Epilepticus

NCT01796574 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2017-03-14

No results posted yet for this study

Summary

This research is being done to observe the safety, tolerability, side effects, and effectiveness of the ketogenic diet in people with continuous seizures (status epilepticus) being treated in a neurointensive care unit.

Conditions

  • Status Epilepticus
  • Seizure
  • Epilepsy
  • Refractory Status Epilepticus
  • Medically Resistant Status Epilepticus

Interventions

DIETARY_SUPPLEMENT

Ketogenic diet

4:1 ratio fat: carbohydrates and protein ketogenic liquid via enteral feed

Sponsors & Collaborators

  • Mayo Clinic

    collaborator OTHER
  • Queen's Medical Center

    collaborator OTHER
  • Rush University Medical Center

    collaborator OTHER
  • Oregon Health and Science University

    collaborator OTHER
  • Thomas Jefferson University

    collaborator OTHER
  • Intermountain Medical Center

    collaborator OTHER
  • NYU Langone Health

    collaborator OTHER
  • University of Rochester

    collaborator OTHER
  • Johns Hopkins University

    lead OTHER

Principal Investigators

  • Mackenzie C. Cervenka, MD · Johns Hopkins University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2017-03-31
Completion
2017-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01796574 on ClinicalTrials.gov